News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • A federal judge will hear May 14 arguments challenging Trump's executive order tightening mail-in voting rules.
  • European equity benchmarks rose broadly, and Italy's blue-chip index hit a record high.
  • Blackstone Digital Infrastructure Trust began trading in New York after a $1.75 billion IPO, opening at the $20 issue price.
  • Boeing shares fell about 4.4% even after an announced China agreement to buy 200 jets, as order details remained unclear.
  • Germany's 10-year yield stayed near multi-year highs, increasing market odds of ECB rate hikes starting in June.
  • A partial collapse of Cuba's power grid caused widespread blackouts and sparked protests across the country.

Latest Articles

KeyBanc Keeps Sector Weight on Avista After 2025 RFP Selections; Capital Plan, Rate Filing Highlight Path Forward

KeyBanc Keeps Sector Weight on Avista After 2025 RFP Selections; Capital Plan, Rate Filing Highlight Path Forward

KeyBanc has reaffirmed a Sector Weight rating on Avista (AVA) after the utility announced the winners of its 2025 Request for Proposals. The selected portfolio, which combines company-owned resources and power purchase agreements, is expected to drive $250 million to $350 million of incremental capital and may support an uplift to Avista's long-ter…

FDA Lifts Hold on Intellia’s Nerve-Disease Gene Therapy Trial, Enabling Restart of Patient Enrollment

FDA Lifts Hold on Intellia’s Nerve-Disease Gene Therapy Trial, Enabling Restart of Patient Enrollment

The U.S. regulator has lifted a clinical hold on Intellia Therapeutics’ late-stage trial of its CRISPR-based therapy, nexiguran ziclumeran, in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN). Intellia said it will resume patient enrollment as soon as possible after agreeing to enhanced safety monitoring measures. A…

HSBC Advises Investors to Maintain Aggressive Risk-On Posture

HSBC Advises Investors to Maintain Aggressive Risk-On Posture

HSBC is urging clients to stay positioned for further gains in risk assets, remaining overweight equities, high-yield credit, emerging-market debt and gold, while underweighting developed-market sovereigns, investment-grade credit and oil. The bank says geopolitics is secondary to U.S. rates, rates volatility and near-term growth expectations, and …

TSX Futures Inch Up as Commodities Gain; Markets Await Fed, BoC Decisions

TSX Futures Inch Up as Commodities Gain; Markets Await Fed, BoC Decisions

Futures tied to Canada’s primary stock index moved modestly higher as gains in gold and silver helped offset other headwinds. Investors are positioning ahead of Federal Reserve and Bank of Canada policy meetings, with U.S. futures trading mixed and commodities - notably gold and crude - showing notable strength amid trade tensions and severe winter…